HOTH
NASDAQ · Pharmaceuticals
Hoth Therapeutics Inc
$0.40
-0.04 (-9.09%)
Open$0.44
Previous Close$0.44
Day High$0.44
Day Low$0.38
52W High$2.45
52W Low$0.43
Volume—
Avg Volume328.0K
Market Cap30.69M
P/E Ratio—
EPS$-0.81
SectorPharmaceuticals
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 4.55M | 4.47M | 5.09M |
| Net Income | 883.9K | 919.3K | 807.7K |
| Profit Margin | 19.4% | 20.6% | 15.9% |
| EBITDA | 1.12M | 1.15M | 1.14M |
| Free Cash Flow | 1.08M | 1.03M | 790.7K |
| Rev Growth | +13.3% | +17.8% | +20.0% |
| Debt/Equity | 0.67 | 0.60 | 0.55 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |